Skip to content

Clinical trials

Terminated Phase 2/3 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2/3 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20121
20131
20143
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CG Oncology, Inc.1
Clovis Oncology, Inc.1
Hoffmann-La Roche1
Kaiser Permanente1
Maria J.G.T. Vehreschild1
Proton Collaborative Group1
Tyme, Inc1
UConn Health1
University of Aarhus1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms10
Neoplasm Metastasis2
Prostatic Neoplasms2
Adenoma, Islet Cell1
Adenoviridae Infections1
Anemia1
Carcinoma in Situ1
Carcinoma, Islet Cell1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.